Sulmet

Glibenclamide + Metformin + Rosiglitazone is a combination of three antidiabetic medicines: Glibenclamide + Metformin + Rosiglitazone1, Glibenclamide + Metformin + Rosiglitazone2 and Glibenclamide + Metformin + Rosiglitazone3. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glibenclamide + Metformin + Rosiglitazone1 is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Glibenclamide + Metformin + Rosiglitazone2 is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Glibenclamide + Metformin + Rosiglitazone3 is a thiazolidinedione which further increases insulin sensitivity. Glibenclamide, Metformin and Rosiglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glibenclamide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione which further increases insulin sensitivity.